Signaturefd, LLC Intercept Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$12.53 - $21.71 $1,140 - $1,975	91 Added 293.55%	122 $1,000
Q4 2022 Jan 27, 2023	BUY	$11.61 - $16.11 $197 - $273	17 Added 121.43%	31 $0
Q3 2022 Nov 08, 2022	BUY	$12.21 - $19.7 $170 - $275	14 New	14 $0
Q1 2022 May 02, 2022	SELL	$13.37 - $17.79 $2,821 - $3,753	-211 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$14.28 - $19.53 $3,013 - $4,120	211 New	211 $3,000
Q4 2020 Feb 11, 2021	SELL	$24.48 - $42.47 $612 - $1,061	-25 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$39.09 - $53.44 $977 - $1,336	25 New	25 $1,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.